Daryl C. Drummond,Dmitri B. Kirpotin,Mark Eamon Hayes,Charles Noble,Kevin Kesper,Antoine M. Awad,Douglas J. Moore,Andrew J. O'Brien,Andrew J. OBrien
申请号:
US15661868
公开号:
US20170319573A1
申请日:
2017.07.27
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Irinotecan phospholipid liposomes with improved storage stability are provided, with related methods of treatment and manufacture. The irinotecan liposomes can have reduced formation of lyso-phosphatidylcholine (lyso-PC) during storage, and prior to administration to a patient.